Ko J, Lee H, Jeong H, Kim M, Wee W, Yoon S, et al. Mesenchymal stem/stromal cells precondition lung monocytes/macrophages to produce tolerance against allo- and autoimmunity in the eye. Proc Natl Acad Sci U S A. 2016;113:158-63 pubmed publisher

Kota D, Wiggins L, Yoon N, Lee R. TSG-6 produced by hMSCs delays the onset of autoimmune diabetes by suppressing Th1 development and enhancing tolerogenicity. Diabetes. 2013;62:2048-58 pubmed publisher

Oh J, Lee R, Yu J, Ko J, Lee H, Ko A, et al. Intravenous mesenchymal stem cells prevented rejection of allogeneic corneal transplants by aborting the early inflammatory response. Mol Ther. 2012;20:2143-52 pubmed publisher

Roddy G, Oh J, Lee R, Bartosh T, Ylostalo J, Coble K, et al. Action at a distance: systemically administered adult stem/progenitor cells (MSCs) reduce inflammatory damage to the cornea without engraftment and primarily by secretion of TNF-? stimulated gene/protein 6. Stem Cells. 2011;29:1572-9 pubmed publisher

Danchuk S, Ylostalo J, Hossain F, Sorge R, Ramsey A, Bonvillain R, et al. Human multipotent stromal cells attenuate lipopolysaccharide-induced acute lung injury in mice via secretion of tumor necrosis factor-α-induced protein 6. Stem Cell Res Ther. 2011;2:27 pubmed publisher

Lee R, Pulin A, Seo M, Kota D, Ylostalo J, Larson B, et al. Intravenous hMSCs improve myocardial infarction in mice because cells embolized in lung are activated to secrete the anti-inflammatory protein TSG-6. Cell Stem Cell. 2009;5:54-63 pubmed publisher